As we head into 2023, here's a look back at a year that saw dealmaking slow into year-end amid rising interest rates by central banks, with three of the top five deals fraught with...
By Daniel Shvartsman Investing.com -- Entering the last trading day of the year, it's no surprise to find the 2022 scoreboard filled with energy winners and tech losers. The Dow...
U.S. stocks suffered their worst losses since 2008 The market could move higher in 2023 if the Fed slows interest-rate hikes and geopolitical tensions calm down But don’t...
The market jumped on Powell's dovish comments and soft CPI reading in November However, there's been little follow-through on that rally as investors await further clues from the...
-- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR...
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
| Average | 268.60 (+5.89% Upside) |
| High | 325.00 |
| Low | 180.00 |
| Price | 253.65 |
| No. of Analysts | 21 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Strong Sell | Neutral |
| Technical Indicators | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Sell | Strong Sell | Strong Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 25.64 | 25.91 | 25.37 | +0.21 | +0.83% | 86.48K | Toronto | |||
| 46.81 | 47.90 | 46.62 | -1.00 | -2.09% | 342.32K | Toronto | |||
| 9.72 | 9.77 | 9.36 | +0.240 | +2.53% | 883.23K | Toronto | |||
| 9.72 | 9.79 | 9.63 | 0.00 | 0.00% | 5.76M | Toronto | |||
| 73.04 | 73.58 | 72.78 | -0.22 | -0.30% | 439.52K | Toronto | |||
| 5.50 | 6.20 | 4.32 | +1.20 | +27.91% | 19.48K | CSE | |||
| 7.60 | 7.69 | 7.48 | -0.04 | -0.52% | 814.77K | Toronto | |||
| 0.09 | 0.09 | 0.09 | 0.00 | 0.00% | 0.00 | CSE | |||
| 22.79 | 23.00 | 22.50 | +0.23 | +1.02% | 2.61M | Toronto | |||
| 37.13 | 37.56 | 36.99 | -0.23 | -0.62% | 359.92K | Toronto | |||
| 31.55 | 32.46 | 31.46 | -0.40 | -1.25% | 432.43K | Toronto | |||
| 12.36 | 13.06 | 12.29 | -0.33 | -2.60% | 116.75K | Toronto | |||
| 39.68 | 39.90 | 39.60 | -0.19 | -0.48% | 3.41M | Toronto | |||
| 37.87 | 37.93 | 36.99 | +0.80 | +2.16% | 657.45K | Toronto | |||
| 54.74 | 55.00 | 54.55 | -0.26 | -0.47% | 2.48M | Toronto |